• On the regulatory front, we have 2001 CSO coming into play.
  • That will help UL writers and variable life writers.
  • It reduces the cost of reserves when we provide guarantees to clients.
  • However, the impact on term and UL is probably moderate, probably low.
  • On the variable life side, a number of variable life products out there today do have no-lapse guarantees.
  • The 2001 table will help that.
  • The impact of the new mortality table on life-insurance-retirement-planning (LIRP) sales, cash accumulation sales, is that it will lower the amount of money that you can get into contracts, but I think that still makes it a relatively attractive sale long-term.

-- Thomas P. Kalmbach, assistant vice president of individual life product financial analysis with The Hartford Life Insurance Companies.

⇒  Tom is currently responsible for pricing individual life business, performing experience studies, managing reinsurance relationships and performing miscellaneous financial analysis.

⇒Tom currently serves as the illustration actuary for the individual life line of business for Hartford Life. Tom is an FSA and a member of the American Academy of Actuaries (MAAA). 

2003 - SOA - Variable Life—Product and Distribution Issues, Society of Actuaries - 28p